Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Living with Dementia: I’m Still Here

impassable plaques1 - mid-stage of alzheimer's1 - methamphetamine1 - blood sugar3 - aβ421 - fatuitas1 - memory loss20 - healthy diet1 - guv membrane1 - healthy aging1 - oral health1 - lrp61 - alcohol related dementia1 - mentally weak1 - age-related cognitive disorders1 - huntington's1 - medical history1 - atorvastatin1 - amyloid β1 - alzheimer's disease biomarkers1 - α-synuclein protein2 - diabetes mellitus1 - dementia parkinson's disease1 - incident dementia1 - diagnosis of dementia1 - depressive pseudodementia1 - learning1 - cholinesterase inhibitors1 - donepezil3 - white matter hyperintensities1 -